MMRGlobal CEO Robert H. Lorsch Clear Channel Interview on “The Traders Network” Hosted by Michael Yorba Recap
LOS ANGELES, CA–(Nov 15, 2013) – MMRGlobal, Inc. (OTCQB: MMRF) CEO Robert H. Lorsch was interviewed November 14th on Clear Channel’s business talk radio show The Traders Network hosted by Michael Yorba. The show, which aired on Dallas-Ft. Worth DFW 1190AM radio station, focused on MMRGlobal’s patented MyMedicalRecords Personal Health Record (PHR) products and services and the Company’s intellectual property that has put it at the intersection of the government’s healthcare IT mandates by providing patients with online access to their health information through a Personal Health Record. MMRGlobal is a leading provider of Personal Health Records, MyEsafeDepositBox storage solutions and MMRPro electronic document management and imaging systems for healthcare professionals.
Live interview archive (12min, 1sec):
Network: Clear Channel
Station: DFW 1190AM
Host: Michael Yorba
Lorsch discussed how government initiatives, primarily the HITECH Act and also the Affordable Care Act are driving the adoption of PHRs and the electronic transmission and exchange of patient information. He pointed out that Meaningful Use Stage 2 under the HITECH Act requires eligible professionals to provide more than 50% of patients the ability to view online, download and transmit their health information through a Personal Health Record or similar patient portal within four days of the information being available to the healthcare professional.
Lorsch stated, “Our product (MyMedicalRecords) is the most comprehensive turnkey PHR that connects to any hospital or healthcare provider anywhere in the world. We hold patents on methods and systems to connect patients to healthcare systems and there are government requirements out there that call for getting patients to participate in the management of their medical information.”
Lorsch noted multiple paths to success, “We sell direct to consumer, we sell OEM, we license to OEMs and we get to enforce our intellectual property in the health information technology marketplace. It is difficult with the depth of our portfolio for companies to not somehow meet us somewhere in the food chain.” Lorsch discussed how billions have been allocated by the U.S. government toward the Affordable Care Act and HITECH. Continued Lorsch, “Around the world in the 12 countries where our patents are already issued, it is a $1 trillion market. Almost every country in the world is going to eHealth and we are at the forefront of the eHealth market.”
“Patent royalty enforcement is going to make your earnings skyrocket,” stated The Traders Network Host Michael Yorba. “This is a guy who knows what he is doing.”
“It’s always such a great experience to be able to stand up and tell our story in such a public news medium as it was with this interview where we really have a chance to explain what we’re doing and how we’re going to get it done. We look forward to doing more of these types of events going into 2014,” stated Mr. Lorsch.
MMRGlobal, Inc., through its wholly-owned operating subsidiary, MyMedicalRecords, Inc., provides secure and easy-to-use online Personal Health Records (“PHRs”) and electronic safe deposit box storage solutions, serving consumers, healthcare professionals, employers, insurance companies, financial institutions, retail pharmacies, and professional organizations and affinity groups. The MyMedicalRecords PHR enables individuals and families to access their medical records and other important documents, such as birth certificates, passports, insurance policies and wills, anytime from anywhere using the Internet. MyMedicalRecords is built on proprietary, patented technologies to allow documents, images and voicemail messages to be transmitted and stored in the system using a variety of methods, including fax, phone, or file upload without relying on any specific electronic medical record platform to populate a user’s account. The Company’s professional offering, MMRPro, is designed to give physicians’ offices an easy and cost-effective solution to digitizing paper-based medical records and sharing them with patients through an integrated patient portal. Through its merger with Favrille, Inc. in January 2009, the Company acquired intellectual property biotech assets that include anti-CD20 antibodies and data and samples from its FavId™/Specifid™ vaccine clinical trials for the treatment of B-Cell Non-Hodgkin’s lymphoma. To learn more about MMRGlobal, Inc. visit www.mmrglobal.com. View demos and video tutorials of the Company’s products and services at www.mmrtheater.com.
A CommPro Worldwide PR Event
Statements in this press release and interview that are not strictly historical in nature, including, without limitation, intellectual property enforcement actions, infringement claims or litigation, intellectual property licenses, and future performance, management’s expectations, beliefs, intentions, estimates or projections, constitute “forward-looking statements.” Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause MMR’s actual results to be materially different from historical results or from any results expressed or implied by such forward-looking statements. Some can be identified by the use of words (and their derivations) such as “need,” “possibility,” “potential,” “intend,” “offer,” “development,” “if,” “negotiate,” “when,” “begun,” “believe,” “achieve,” “will,” “estimate,” “expect,” “maintain,” “plan,” and “continue,” or the negative of these words. Actual outcomes and results of operations and the timing of selected events may differ materially from the results predicted, and any reported results should not be considered as an indication of future performance. Such statements are necessarily based on assumptions and estimates and are subject to various risks and uncertainties, including those relating to the possible invalidity of the underlying assumptions and estimates and possible changes or developments in economic, business, industry, market, legal and regulatory circumstances and conditions and actions taken or omitted to be taken by third parties, including customers, suppliers, business partners, potential licensees, competitors and legislative, judicial and other governmental authorities and officials. Factors that could cause or contribute to such differences include, but are not limited to: unexpected outcomes with respect to intellectual property enforcement actions, claims of intellectual property infringement and general intellectual property litigation; our ability to maintain, develop, monetize and protect our patent portfolio for both MMR’s health IT and biotechnology intellectual property assets in the U.S. and internationally; the timing of milestone payments in connection with licensing our intellectual property; our ability to establish and maintain strategic relationships; changes in our relationships with our licensees; the risk MMR’s products are not adopted or viewed favorably by the healthcare community and consumer retail market; business prospects, results of operations or financial condition; risks related to the current uncertainty and instability in financial and lending markets, including global economic uncertainties; the timing and volume of sales and installations; the length of sales cycles and the installation process; the market’s acceptance of new product and service introductions; competitive product offerings and promotions; changes in government laws and regulations including the 2009 HITECH Act and changes in Meaningful Use and the 2010 Affordable Care Act; future changes in tax legislation and initiatives in the healthcare industry; undetected errors in our products; the possibility of interruption at our data centers; risks related to third party vendors; risks related to obtaining and integrating third-party licensed technology; risks related to a security breach by third parties; risks associated with recruitment and retention of key personnel; other litigation matters; uncertainties associated with doing business internationally across borders and territories; and additional risks discussed in MMR’s filings with the Securities and Exchange Commission. MMR is providing this information as of the date of this release and, except as required by applicable law, does not undertake any obligation to update any forward-looking statements contained in this release as a result of new information, future events or otherwise.
PR & Media Contact:
Matt Bird, CEO
C: +1 (646) 401-4499